Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference

Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference